JUBLINGREA Just Broke Out Big after Prabhudas Lilladher gave Hold Rating with a target of Rs 713 and Stake Sell from PromotersTechnical Chart Pattern:
• The stock displays a classic ascending triangle pattern formation spanning from February to June 2025
• Multiple higher lows connected by an ascending trend line (white diagonal support)
• Horizontal resistance zone around ₹735-740 levels acting as the upper boundary
• Recent breakout above the triangle pattern with strong volume confirmation
Key Support and Resistance Levels:
• Primary Support: ₹675-685 (previous resistance turned support)
• Secondary Support: ₹650-660 (trend line support)
• Major Support: ₹535-550 (swing low from March)
• Immediate Resistance: ₹800-810 (psychological level)
• Major Resistance: ₹885 (all-time high marked on chart)
Base Formation Analysis:
• Well-defined base formation between ₹650-740 levels over 4 months
• The consolidation phase showed declining volatility, indicating accumulation
• Multiple tests of resistance at ₹735-740 showing supply absorption
• Base depth of approximately 15-20% from the highs, indicating healthy correction.
Volume Spread Analysis:
Volume Characteristics:
• Significant volume spike during the recent breakout (26.85M vs average 1.75M)
• Volume expansion during upward moves and contraction during pullbacks
• Strong institutional participation is evident from the volume profile
• Volume-price correlation remains positive, supporting the uptrend
Volume Indicators:
• Above-average volume during breakout confirms genuine demand
• Recent sessions show sustained higher volumes, indicating continued interest
• No distribution patterns are visible in volume analysis
Trade Setup:
Entry Strategy:
• Primary Entry: ₹790-800 on any pullback to the breakout zone
• Aggressive Entry: Current market price around ₹799 with tight stops
• Conservative Entry: Wait for retest of ₹740-750 resistance-turned-support
• Scale-in approach recommended given the momentum
Exit Levels:
• Target 1: ₹850 (measuring the triangle height projection)
• Target 2: ₹885 (previous all-time high)
• Target 3: ₹920-950 (extended projection based on base depth)
• Trail stops above ₹850 for position management
Stop Loss Placement:
• Initial Stop Loss: ₹735 (below breakout level)
• Revised Stop Loss: ₹750 (after first target achievement)
• Final Stop Loss: ₹780 (trailing stop for remaining position)
Risk Management Framework:
Position Sizing Guidelines:
• Risk 1-2% of portfolio capital per trade
• Position size calculation: (Account Size × Risk %) ÷ (Entry Price - Stop Loss)
• Maximum position should not exceed 3-5% of the total portfolio
• Consider reducing the size given recent volatility expansion
Risk Control Measures:
• Maintain risk-reward ratio of a minimum of 1:2
• Use partial profit booking at predetermined levels
• Avoid averaging down below stop loss levels
• Monitor sector rotation and market sentiment
Fundamental and Sectoral Backdrop:
Company Overview:
• Jubilant Ingrevia operates in Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates segments
• Global provider serving pharmaceutical, nutrition, agrochemical, and consumer industries with a focus on quality and customization
• Serves 15 of the top 20 Global Pharma & 7 of the top 10 Global Agrochemical companies as a leading low-cost provider
Recent Financial Performance:
• Net profit jumped 153.16% year-over-year to ₹74.05 Cr in Q4 2024-2025
• Q4 2025 revenue of 1,051 cr. down from INR1,074 cr. in Q4 FY24 with EBITDA of INR148 crores showing 42% year-on-year rise
• Market capitalization of 12,664 Cr. with trailing twelve-month revenue of 4,178 Cr.
Sectoral Dynamics:
• The speciality chemicals sector is benefiting from the China+1 strategy
• Increasing demand for pharmaceutical intermediates post-COVID
• The government push for self-reliance in chemical manufacturing
• Export opportunities in agrochemical intermediates are expanding globally
Key Fundamentals:
• The company shows a low return on equity of 9.24% over the last 3 years
• Analyst average share price target of ₹735
• Strong client base with global pharmaceutical and agrochemical giants
• Diversified product portfolio, reducing concentration risk
Market Outlook and Catalysts:
Positive Catalysts:
• Expansion in speciality chemicals capacity
• New product launches in the nutrition segment
• Increasing penetration in international markets
• Potential margin expansion through product mix improvement
Risk Factors:
• Raw material price volatility
• Regulatory changes in target markets
• Currency fluctuation impact on exports
• Competition from Chinese manufacturers
My Take:
This technical setup presents a compelling opportunity with the stock breaking out of a well-defined pattern, supported by strong fundamentals and favourable sector dynamics. The risk-reward profile appears attractive for traders and investors willing to manage position size appropriately.
Keep in the Watchlist.
NO RECO. For Buy/Sell.
📌Thank you for exploring my idea! I hope you found it valuable.
🙏FOLLOW for more
👍BOOST if you found it useful.
✍️COMMENT below with your views.
Meanwhile, check out my other stock ideas on the right side until this trade is activated. I would love your feedback.
Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER."
This analysis is intended solely for informational and educational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.